Huron Capital sells Quest Specialty Chemicals

Huron Capital sells Quest Specialty Chemicals

3:18 PM, 10th June 2011
Huron Capital sells Quest Specialty Chemicals
Mike Beauregard, Partner at Huron.

DETROIT, US: Huron Capital said that it has sold its interest in Quest Specialty Chemicals Inc in a transaction that produced 4.1 times its original investment.  In order to give effect to the transaction, Quest was recapitalized by Audax Group, Moelis Capital Partners, and Quest management.  Huron’s investment in Quest was the 2nd largest equity investment made through The Huron Fund II, LP, a $ 185,000,000 fund which had its final close in May 2005.

 

Founded in 2003 by Huron and chemical industry veterans Frederick Quinn and Gerard Loftus, Quest is a leading specialty chemicals company engaged in the formulation, manufacturing, and marketing of coatings designed to repair, restore, and preserve the assets of its customers. The Quest platform purchased seven companies: Raabe Company (2004), Foxcolor (2005), Matrix System Automotive Finishes (2006), United Coatings (2007), Zolatone (2007), HydroStop (2007) and Custom Finishes (2009).  During Huron’s hold period, the business reviewed over 200 acquisition opportunities and enjoyed sales and EBITDA growth of 426 per cent and 481 per cent, respectively. 

 

“This transaction marks the realization of a core position for the fund. Fred and Gerry brought a unique combination of corporate development and operating talent to the business. Together, we built the depth of the Quest team methodically with each add-on acquisition. This made Huron comfortable injecting fresh equity into the business on four separate occasions. We are grateful for the dedicated and transformational leadership skills that Fred and Gerry invested into the company,” said Mike Beauregard, Partner at Huron.

(C) WOC News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


ChemSec asks EU to limit use of endocrine disrupting chemicals

ChemSec has released a list of 22 substances that harms endocrine. It has called for the European Commission to take priority action in EU against the ...

Read more
Bayer posts good results on high volumes and pricing

Sales up by 13.2 per cent to € 9,415 million / Operating result (EBIT) rises by 4 per cent to € 1,148 million / EBITDA before special item ...

Read more
Toyo awarded contract to build first butadiene plant in Indonesia

  TOKYO, JAPAN: Toyo Engineering Korea Ltd, subsidiary of Toyo Engineering has been awarded a contract to build a butadiene plant to be cons ...

Read more
AkzoNobel to get new CEO, Ton Büchner

  AMSTERDAM, THE NETHERLANDS: The Supervisory Board of Akzo Nobel N V announced that Hans Wijers, Chief Executive Officer, has decided to step d ...

Read more
DuPont Titanium Technologies increases price for products in North America

WILMINGTON, US: Effective April 1, 2011, DuPont Titanium Technologies announces a price increase of 15 cents per pound (USD), or as permitted by con ...

Read more
Analytical instrumentation focuses on feature–rich technology

DUBAI INTERNATIONAL EXHIBITION CENTRE, DUBAI: As a benchmark event, the ARABLAB 2011 reflected some of the growing industry trends. Growth across al ...

Read more